Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro
© Schinwald et al.; licensee BioMed Central Ltd. 2012
Received: 17 October 2012
Accepted: 26 November 2012
Published: 2 December 2012
The objective of this study was to examine the threshold fibre length for the onset of pulmonary inflammation after aspiration exposure in mice to four different lengths of silver nanowires (AgNW). We further examined the effect of fibre length on macrophage locomotion in an in vitro wound healing assay. We hypothesised that exposure to longer fibres causes both increased inflammation and restricted mobility leading to impaired clearance of long fibres from the lower respiratory tract to the mucociliary escalator in vivo.
Nine week old female C57BL/6 strain mice were exposed to AgNW and controls via pharyngeal aspiration. The dose used in this study was equalised to fibre number and based on 50 μg/ mouse for AgNW14. To examine macrophage migration in vitro a wound healing assay was used. An artificial wound was created in a confluent layer of bone marrow derived macrophages by scraping with a pipette tip and the number of cells migrating into the wound was monitored microscopically. The dose was equalised for fibre number and based on 2.5 μg/cm2 for AgNW14.
Aspiration of AgNW resulted in a length dependent inflammatory response in the lungs with threshold at a fibre length of 14 μm. Shorter fibres including 3, 5 and 10 μm elicited no significant inflammation. Macrophage locomotion was also restricted in a length dependent manner whereby AgNW in the length of ≥5 μm resulted in impaired motility in the wound closure assay.
We demonstrated a 14 μm cut-off length for fibre-induced pulmonary inflammation after aspiration exposure and an in vitro threshold for inhibition of macrophage locomotion of 5 μm. We previously reported a threshold length of 5 μm for fibre-induced pleural inflammation. This difference in pulmonary and pleural fibre- induced inflammation may be explained by differences in clearance mechanism of deposited fibres from the airspaces compared to the pleural space. Inhibition of macrophage migration at long fibre lengths could account for their well-documented long term retention in the lungs compared to short fibres. Knowledge of the threshold length for acute pulmonary inflammation contributes to hazard identification of nanofibres.
KeywordsAsbestos fibre Silver nanofibres Aspiration Clearance Migration
Backscatter scanning electron microscopy
Bone marrow derived macrophages
Fibre pathogenicity paradigm
Long fibre amosite asbestos
Scanning electron microscopy
Short fibre amosite asbestos
The determinants of the pathogenicity of fibrous materials include fibre diameter, length and biopersistence which form the basis of the fibre pathogenicity paradigm (FPP) . Studies on asbestos fibres, synthetic vitreous fibres and nanofibres have shown that they all may pose a significant health hazard when inhaled during their manufacture and/or use [2–5]. These various different fibrous materials possess considerable differences in their pathogenicity in keeping with the FPP . It has been accepted for many years that fibre length plays a crucial role in the development of asbestos related diseases. For example Davis et al. performed a number of experiments investigating the pathogenicity of various length and compositions of asbestos fibres via the routes of inhalation and intraperitoneal injection [7, 8]. The inhalation studies showed that fibres with a significant proportion (~11%) of fibres > 10 μm caused widespread pulmonary fibrosis and cancer whereas shorter fibres (less than 5 μm) and UICC amosite (intermediate length) caused less fibrosis or carcinogenesis. However, the UICC amosite fibres and long asbestos fibres had similar potency in causing mesothelioma whilst virtually no carcinogenicity was seen with short fibres . This study showed for the first time a difference in the fibre lengths required for the induction of lung diseases and the lengths for peritoneal mesothelioma and by analogy pleural mesothelioma. However, the precise threshold lengths for both lung and peritoneal pathology after fibre exposure were unknown at the time. In a recent study we determined the threshold length for fibre-induced pathogenicity in the pleura  as being 5 μm, using distinct length classes of silver nanowires (AgNW). The aim of the current study was to determine the threshold length for fibre-induced lung inflammation by comparing the pulmonary inflammatory response to the same panel of different length classes of AgNW after their deposition in the airspaces of the lungs.
The normal lung clearance mechanisms provide a defence mechanism for removing fibre dose and yet selective retention of longer fibres is well-documented [10, 11]. For the key fraction of fibres that deposit beyond the ciliated airways and are slowly cleared, macrophage are the central cells involved in phagocytosing and transporting the fibres to the foot of the mucociliary escalator for clearance. We therefore hypothesised that the uptake of long fibres impairs the ability of macrophages to migrate whilst short fibres do not, providing a mechanism for selective retention of long fibres. We addressed this hypothesis using the samples with different fibre length classes and assessed their effects on macrophage migration in an in vitro wound closure assay.
Length dependent inflammatory response to AgNW in lung at 24 hour
Calculation for the mass adjustments for equalisation of fibre number in vivo
Calculation to equalise for the same fibre number
Total fibre number
Short fibre control
3/14 × 50
5/14 × 50
10/14 × 50
Long fibre control
Histological evaluation of lung sections following treatments
Frustrated phagocytosis in alveolar macrophages
Fibre-length dependent inhibition of locomotion in bone marrow derived macrophages
Screening for kinase phosphorylation in BMMs after AgNW treatment
The aim of this study was to investigate length-dependent effects of AgNW in the lungs. To assess the role of fibre length in the initiation of inflammation the BAL profile was assessed after aspiration exposure. To assess the effect of length on macrophage clearance and retention of the long fibre dose we used an in vitro wound-healing assay. The latter study aimed to shed light onto the effects of fibre length on clearance of fibre-laden alveolar macrophages via migration from the alveolar region of the lung to the mucociliary escalator.
Fibre dimension is a critical factor for lung diseases after inhalation exposure of various forms of fibrous materials as demonstrated in a number of experimental studies, with long fibres being more pathogenic than short ones [7, 8, 13, 14]. We recently reported a length threshold of 5 μm for inflammation in the pleural cavity using the same range of tightly length –defined silver nanowires used here .
Long term inhalation studies in rat have been performed with amosite asbestos preparations of short (1% > 5 μm), medium (UICC reference fibre) and long (30% > 5 μm, 11% > 10 μm). These studies showed that the short fibres and the slightly longer UICC sample were low in pathogenicity whilst the long fibres induced extensive fibrosis and pulmonary adenomas. This was in contrast to the studies performed using direct injection of the same samples of amosite asbestos into the peritoneal cavity which showed that UICC amosite was sufficiently long to cause mesothelioma in rats at the same frequency as long amosite fibres . This supports findings of the present study, that the length threshold for fibre effects in the lung is different to the length threshold for fibre effects at the mesothelial surface, the lung threshold being a higher value. More recent studies on adverse effects of nanofibres have shown a positive correlation between increasing fibre length and greater lung and pleural/peritoneal inflammation [4, 15, 16]. Poland et al. showed severe lung and peritoneal inflammation after aspiration exposure and direct intraperitoneal injection in mice of long (24 μm) nickel nanowire but only very mild diffuse alveolitis and mild peritoneal inflammation after exposure to short (4 μm) nickel nanowires . Similar results were obtained from studies on short (<1 μm) and long (>13 μm) carbon nanotubes where the resultant pathophysiological response was compared to short and long amosite asbestos fibres [15–17]. These studies have shown that carbon nanotubes (CNT) induce a length- dependent inflammation in the peritoneal and pleural space of mice [15–17].
We recently investigated the threshold length for pleural inflammation and reported that various forms of high aspect ratio nanomaterials including amosite asbestos fibres, carbon nanotubes, nickel nanowires and the silver nanowires used here, showed a clear length threshold of 5 μm for initiation of an inflammatory response in the pleural space after direct intrapleural injection . The data clearly showed that fibres below 5 μm in length were non-inflammatory and that fibres 5 μm in length and longer caused extensive recruitment of inflammatory cells [9, 18] to the pleural space.
The current study addressed the lack of knowledge regarding the threshold length for acute pulmonary inflammation after deposition in the airspaces of the lungs. The pulmonary response to AgNW reported here showed a threshold length for the significant recruitment of inflammatory cells of 14 μm compared to the 5 μm fibre threshold length for pleural inflammation [9, 18]. The use of size categories means that the actual threshold could lie anywhere between 11- and 14 μm since the size category below, at which no inflammation was produced was 10 μm. Our finding of a longer threshold in the lungs is consistent with previous reports implicating longer fibres in the development of lung carcinoma compared to mesothelioma [8, 9]. The different length thresholds for pulmonary versus pleural inflammation can be explained as a consequence of the different mechanisms of fibre clearance from the lung and the pleural/ space. Clearance of fibres from the pleural space is via lymphatic drainage to mediastinal lymph nodes through stomata, pores in the parietal pleura which are around 0.5–10 μm in diameter . Therefore a size- restricted clearance occurs in the pleural space leading to a retention of fibres which cannot negotiate the stomata and subsequent recruitment of inflammatory cells . The clearance mechanism in the lung relies on alveolar macrophage phagocytosis and migration to the foot of the mucociliary escalator and is discussed in more detail below.
Summary of the length-dependent effects of fibres in the lungs
Δ kinase phosphorylation*****
The clearance efficiency of deposited fibres from the lower respiratory tract plays a major role in the development of pulmonary diseases since the retained dose, which is the dose accumulated in the alveolar region of the lungs after clearance mechanism accounts for the chronic pathogenic effects of inhaled fibres .
Fibres deposited in the conducting airways are cleared rapidly via cilia in the mucociliary escalator and subsequently swallowed or expectorated. If fibres reach the respiratory bronchioles, alveolar ducts or alveolar sacs they are cleared slowly via alveolar macrophages (AM) phagocytosing the deposited fibres and transporting them upwards to the ciliated airways for mucociliary clearance. It has been noted in many studies that there is selective retention of long biopersistent fibres of various sorts from the slow-clearing compartment with more effective clearance of the shorter fibres [11, 23].
The mechanism by which fibre-laden alveolar macrophages are drawn to the terminal bronchioles at the foot of the ciliated airways is obscure. Possible explanations include the passive transport with alveolar fluid or amoeboid movement of AM either by random migration or directed migration along a chemotactic gradient . Other pathways of clearance, usually only important during high dust exposure or disease are intra- and transcellular pathways by which fibres can reach lung interstitium and lymph nodes from where they subsequently may reach the blood stream [22, 25, 26]. A recent study investigated the effects of MWCNT on cell migration and adhesion of human dermal fibroblasts and murine fibroblasts, reporting a significant decrease in cell adhesion which was confirmed by the decrease of mRNA levels of important cell adhesion proteins FAK, fibronectin and laminin . In addition fibroblast migration in a wound- healing assay was greatly impaired by MWCNT treatment and was accompanied by cytoskeletal derangement , although it should be noted that the dose of MWCNT used in this study was cytotoxic to human fibroblast which could influence the adherence and migration properties of the cells.
We set out to investigate whether fibre length has an effect on the migration behaviour of BMMs in vitro after fibre exposure using a wound-healing assay, a surrogate for in vivo clearance of fibrous material to the mucociliary escalator by AM migration. We used a very low dose to study effects on BMM migration, based on 2.5 μg/cm2 for AgNW14 and all the other length classes were adjusted to provide the same fibre number. The dose used had no significant effect on cell metabolism or cell viability for any of the length classes, ensuring that the observed effects were not due to simply impaired cell viability. A clear length-dependent trend for inhibition of BMM cell migration was measured at fibre lengths of 5, 14 and 28 μm and at 28 μm there was more-or less complete inhibition of motility. Presumably as a consequence of cell surface extension of AM during engulfment of long fibres, increased cell spreading was observed and correlated with increased inhibition of migration. The BMMs in this study had an average diameter of 13 μm  whilst human alveolar macrophages have an average diameter of 21 μm . Due to this difference the threshold length for clearance of fibres by alveolar macrophages in humans may be slightly higher.
An initial screening of 46 kinase phosphorylation sites was performed to get a snapshot of the kinase activation status of fibre- treated BMMs. We hypothesised that this might reveal whether there was any fundamental change in the activation/metabolic state of the cells when they were impaired in their ability to migrate by phagocytosing long fibres. The 3 μm long exposed cells act as a control for normal phagocytosis and when compared to the untreated kinase profile this showed most of the kinases (~32) remained unchanged. The kinases GSK-3 α/β, Akt 473, β-catenin and PLC-γ showed activation in all treatment groups suggesting a link to normal phagocytosis. Comparing the kinase phosphorylation profile of BMM exposed to 3 μm with those exposed to 14 μm should reveal differences associated with the long fibre-dependent loss of motility and 5 kinases out of 46 (STAT3, p53 (S392), p27 (T198), p27 (T157) and p70 S6 (T389)) exhibited increased phosporylation with AgNW14 compared to AgNW3. Tyrosine kinases of the Src family were noticeably induced by treatment with long fibres. These kinases have been implicated in intracellular signalling in macrophages influencing the amplitude of many pathways . One of the Src downstream effectors is STAT3, a major modulator of inflammation, which is required for activation of macrophages . A marked Induction of STAT3 following the AgNW14 treatment is a likely result of Src activation. It’s worth mentioning that a constitutive activation of STAT3 is a common feature in many solid tumours , therefore persisting activation of STAT3 in a chronic inflammation caused by long fibres may contribute to pro-oncogenic changes. Macrophage motility is known to be negatively regulated by p53  and the latter was induced in BMM treated with longer fibres, and might have contributed to impairment of their migration. The role of p27 in regulation of cellular migration remains unclear, however, our finding would support the reports showing suppression of migration by induction of p27 . No kinases were down-regulated in the long fibre treated BMM compared to the controls confirming that there was no generalised loss of viability associated with failure to migrate. It is reported in the literature that a number of different kinase pathways are involved in the migration and adhesion processes among these are kinases that showed an increase in their phosphorylation state after long fibre treatment [35–41]. The results from the screening of the phosphorylation sites was mainly performed to see if crucial cellular signalling processes are impaired by the treatment of AgNW which might indicate that decreased cellular function, apoptosis/necrosis underlay the decrease in cell mobility. Our results showed that the long-fibre treatment did not negatively affect the cellular function of the BMMs as assessed by metabolic function, loss of membrane integrity or kinase profile. In fact long fibre treatment and inhibition of motility were associated with increased phosphorylation of some kinases involved in migration and adhesion. Clearly the interplay between adhesion and motility is complex since focal adhesion is required for motility and a more sophisticated analysis of mechanism underlying loss of motility with long fiber treatment is required but is outwith the scope of the present paper. The results give an indication that cellular processes are intact in long fiber treated BMM and therefore that inhibition of locomotion can be best explained via a mechanical obstruction to motility. By this we suggest that the presence of long fibres inside the cells physically interferes with the necessary rearrangement of the cytoskeleton, membrane and other structures that are necessary for locomotion. This however has to be confirmed by an in depth investigation of the molecular mechanism involved in inhibition of migration which is beyond the scope of the present manuscript.
In conclusion we have shown that there are length-dependent effects on the lung and on BMM summarised in Table 2. These show length-dependent increases in inflammation by BAL and severity of lung injury by histology in vivo and evidence of accompanying impairment of macrophage migration by BMM in vitro; frustrated phagocytosis was only evident at the longest fibre lengths indicating that complete uptake of longer fibres still causes cell impairment, in the absence of classical frustrated phagocytosis as we previously reported [9, 12]. A threshold length for acute pulmonary inflammation after pharyngeal aspiration of AgNW was evident between 10 and 14 μm in length. This compares with our previous studies on the threshold length for pleural inflammation of 5 μm, determined using a panel that utilised the AgNW used here . No previous study has used tight length- restricted fibre populations to demonstrate thresholds as shown here and in our previous study in the pleural space . The present study showing that the threshold length for induction of pulmonary inflammation is longer than the threshold length for pleura inflammation is in accordance with extrapolations using asbestos fibres . The difference in thresholds can be explained by the differences in clearance mechanism between the lung the pleural space. In the pleural space clearance is through stomata  whilst clearance of deposited fibres from beyond the ciliated airways is via uptake by AM and subsequent migration to the mucociliary escalator. Using an in vitro wound healing assay we showed that fibre length-dependent macrophage mobility, with a threshold for impairment at a length of 5 μm and increasing impairment with increasing length, until at 28 μm there was almost complete inhibition of motility. An explanation for the decrease in locomotion could be mechanical obstruction caused simply by the bulky long fibres interfering with the movement process since there was no loss of viability or respiration in the long fibre-treated cells and an initial screen of a number of 46 kinases showed no decrease kinase phosphorylations. We note however that this is a small-scale aspiration study with acute inflammation and short term inhibition of migration in vitro as the endpoints. Our results need to be confirmed in long term inhalation studies using a range of different nanofibres at plausible exposure before we can confidently utilize these thresholds for risk assessment and in benign-by-design for nanofibres.
The panel of particles investigated here consisted of four silver nanowires (AgNW) samples (Figure 1), a silver nanoparticle control (AgP) and two amosite asbestos samples, long amosite asbestos (LFA) and short amosite asbestos (SFA) as previously described in Schinwald et al. . AgP was purchased from Nanostructured & Amorphous Materials, Inc. with a diameter of 35 nm, a purity of 99,5% and a specific surface area of 30–50 m2/g. The AgNW samples were kindly provided by Seashell Technology, San Diego (http://www.seashelltech.com). The polyol process was used for the synthesis of the AgNW which is described in patent number 7,922,787 B2. Detailed description of particle panel characteristics including concentration of soluble metal and dissolution can be found in Schinwald et al. . AgNW synthesis and reaction conditions to obtain different lengths did not affect the chemical composition of the different nanowires and no coating of the nanowires was performed. The panel was dispersed in isopropanol and diluted to a working concentration of 1 mg/ml in 0.5% bovine serum albumin (BSA; Sigma-Aldrich, Poole, UK)/saline. For light microscope images the AgNW (1 mg/ml) were were mixed with 10 μl of glycerol (Sigma-Aldrich, Poole, UK) to reduce the flow of AgNW. The suspension was placed on glass slide and covered with a glass coverslip and sealed . Images were captured at x40 magnification using QCapture Pro software (Media Cybernetics). As a control panel mixed length amosite asbestos enriched for long fibres (100% fibres ≥5 μm, 50.3% fibres >15 μm, 35.2% fibres >20 μm), hereafter referred to as long fibre asbestos (LFA), and shortened amosite asbestos (SFA; 3.1% fibres ≥5 μm, mean length 1 μm, mean diameter 300 nm)  were used.
Nine week old female C57BL/6 strain mice (Harlan, UK) were used in this study. Mice were kept in a group size of five in standard caging with sawdust bedding within a pathogen-free Home Office approved facility. Mice were maintained on a normal 12 hour light and dark cycle. Prior to the treatment mice were kept for 7 days in the facility to acclimatise. The work was carried out by staff holding a valid UK Home Office personal licence under a Home Office approved project licence.
Pharyngeal aspiration and bronchoalveolar lavage
The dose of AgNW panel for pharyngeal aspiration was equalised to fibre number since fibre exposure is regulated on the basis of the fibre number and so relative potency needs to be determined on a per-fibre basis. To equalise for fibre number a dose of 50 μg/mouse for AgNW14 was chosen as the standard in vivo dose based on previous measurement of membrane integrity and proliferation. Based on 50 μg/mouse for AgNW14, concentrations for the other length classes AgNW panel were calculated assuming that fibres thickness was constant in the different length classes (Table 1). Particle panel was dispersed in 0.5% bovine serum albumin (BSA; Sigma-Aldrich, Poole, U.K.)/saline and briefly vortexed to assist dispersion. Vehicle control (VC) consisted of 0.5% BSA/saline.
Mice were anesthetized with isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1 trifluoroethane) and the tongue was gently held in full extension while 50 μl of particle suspension was pipette onto the base of the tongue . The tongue was held extended until at least two breaths were complete. To stimulate inhalation and to induce a gasp reflex the nasal cavities of the mice were covered. Mice were observed until full recovery.
Mice were sacrificed at 24 hour by terminal anaesthesia. 0.5 ml of pentobarbitone (200 mg/ml) (2, 2, 2-Tribromomethanol) was injected in the peritoneal cavity followed by exsanguinations via the abdominal aorta. The thoracic cavity was exposed and the trachea cannulated using a 23 gauge needle and legated. The lungs were lavaged three times with 800 μl of ice-cold sterile saline. The first lavage was retained separately for LDH and total protein measurements and the subsequent lavages were pooled.
Calculation for total fibre number: e.g. AgNW3
Length of NW (average) [μm] =3.00
Diameter of NW [μm] =0.115
For histological examination of lung pathology no forgoing BAL was performed and n = 2 for each treatment was used. 10% formalin was instilled into the lungs to fix the lung tissue and removed ‘en block’ with the heart. The lung and heart were kept for 4 hours in fixative prior to processing. The heart was removed and the lung was dissected into individual lobes and placed flat in a tissue cassette. The tissue was dehydrated through graded alcohol (ethanol) and embedded in paraffin. 4 μm sections were cut from the block covering all lobes of the lung and stained with H&E to show gross pathology.
Differential cell count/ total protein and lactate dehydrogenase measurement
The cellular fraction was separated from the supernatant of lavage fluid from BAL by centrifugation for 5 minutes at 2000 g at 4°C in a Mistral 3000i centrifuge (Thermo Fisher Scientific, Inc., MA, USA). Total cell count was performed using a NucleoCounter (ChemoMetec, 7 A/S, Allerød, Denmark) and cyto-centrifugation with following Diff-Quik staining using Diff-Quik stainset (Dade Behring Gmbh, Marburg, Germany) were prepared for differential cell counts.
In the supernatant, membrane integrity using the Cytotoxicity Detection Lactate Dehydrogenase kit (Roche 25 Diagnostics Ltd., Burgess Hill, UK) and protein content using the bicinchoninic acid (BCA) protein assay (Sigma-Aldrich, Poole, UK) were measured following the manufacturer’s instructions.
Generation of bone marrow derived macrophages
Bone marrow-derived macrophages (BMMs) were generated from 8 week old wild-type C57/Bl6 mouse femurs and tibias. In brief, the bone marrow was flushed with PBS using a 24 gauge needle, resuspended, passed through a cell strainer and centrifuged at 15000 rpm for 3 min. Cells were resuspended in red blood cell lysis buffer Hybrid Max™ (Sigma- Aldrich, UK) for 5 min at room temperature. Cells were centrifuged, resuspended in DMEM (Dulbecco's Modified Eagle Medium, Life Technologies) containing 10% FCS, 1% penicillin/ streptomycin and 20% L929 cell media and plated in a 10-cm2 non tissue coated dish and cultured for 7 days.
Wound healing assay
Calculation for the mass adjustments for equalisation of fibre number in vitro
Length class [μm]
Calculation to equalise for the same fibre number
Total fibre number
3/14 × 2.5
5/14 × 2.5
28/14 × 2.5
Backscatter scanning electron microscopy
Backscatter scanning electron microscopy is based on elastic scattering of high energy electron further inside the sample. Elements with high atomic numbers (Z) such as silver give a stronger signal then lower Z elements. The signal is in general weak and can therefore only provide a contrast between regions with a larger difference in atomic number .
BMM cells were prepared as described above and seeded into 24 well plates on ThermanoxR Plastic Coverslips (NUNC™, Rochester, NY USA) at a density of 0.5*106/ml. The cells were treated for 30 hours using concentration as described above at 37°C in 5% CO2 atmosphere. After the treatment they were washed 5x with 0.1 M sodium cacodylate (pH 7.2) buffer. Cells were fixed overnight in 3% glutaraldehyde/ 0.1 M sodium cacodylate (pH 7.2) buffer and subsequently washed three times in sodium cacodylate buffer.
BSE of carbon-coated specimens was carried out using a Hitachi 4700 II field emission SEM (Hitachi High-Tech, Maidenhead, UK) at a beam accelerating voltage of 10 kV and a working distance of about 8 mm. Secondary electron (SE) and BSE images were taken simultaneously using an annular YAG crystal BSE detector and the upper SE detector to produce perfectly-synchronised image pairs. Both images were superimposed using Adobe Photoshop. The SE and BSE image were converted to grayscale, the BSE image was pasted into the SE image by using the layer function “lighten”. This newly merged image and the SE image were converted to RGB mode, and overlayed by pasting the red channel of the BSE image into the red channel of the greyscale SE image, thus colour coding in red the strong BSE signal from the nanowires, the SE image appearing in grey.
Measurement of membrane integrity and proliferation of BMMs
Supernatant of the wound healing assay was collected and analysed for membrane integrity using using the Cytotoxicity Detection Lactate Dehydrogenase kit (Roche Diagnostics Ltd., Burgess Hill, UK) following the manufacturer’s instructions. TritonX (Sigma) was used as a positive control for cell death and was added at a final concentration of 0.1% for 30mins. The supernatant was centrifuged for 5 mins at 2000 rpm, transferred and centrifuged again for 5 mins at 13000 rpm. The conversion of lactate to pyruvate was detected using a microplate reader (BioTek® SynergyHT) to measure the optical density at 490 nm. Results are given as the mean ± SEM of 3 independent experiments.
Cells in the culture dish were used to measure their proliferation and metabolic activity via a chemical reduction of AlamarBlue® (Invitrogen). 150 μl of PBS and 15 μl of AlamarBlue® was added to each well and incubated for 3 hours at 37°C in 5% CO2 atmosphere. Absorbance was monitored at 570 nm and 600 nm as a reference wavelength. Data are normalized to 600 nm value. Results are given as the mean ± SEM of 3 independent experiments.
Proteome profiler array
BMMs were differentiated as described above and seeded at 0.5x106/ml in DMEM containing 10% FCS, 1% penicillin/ streptomycin and 20% L929 cell media and culture for 2 days as a confluent monolayer in a 60 mm tissue culture dish. The medium was replaced with DMEM containing 0% FCS and 1% penicillin/streptomycin and the particle panel was added at the concentrations described above and treated for 30 h. The cells were rinsed with cold phosphate-buffered saline (PBS) and immediately solubilised in lysis buffer by pippeting up and down and rocking the cell lysate at 4°C for 30 min. The lysate was centrifuged at 14,000 x g for 5 min, the supernatant was transferred into new test tubes and the protein concentration was measured using the bicinchoninic acid (BCA) protein assay (Sigma-Aldrich, Poole, UK) following the manufacturer’s instructions. 500 μg of lysates were diluted and incubated with the Human- Phospho – MAPK Array Kit (Proteome Profiler™, R&D Systems) as per manufacturer’s instructions. Plots were developed on X-ray films following exposure to chemiluminescent reagents.
All data are shown as the mean ± s.e.m. and these were analysed using one-way analysis of variance (ANOVA). Multiple comparison were analysed using Tukey-HSD method and in all cases, values of P < 0.05 were consider significant. (GraphPad InStat Software Inc., CA, USA).
We thank S. Mitchell (University of Edinburgh) for sample preparation for SEM and technical assistance. We also thank James R. Glass, Janet C. Dickerson and David A. Schultz from Seashell Technology for providing the AgNW samples. This research was funded by the Colt Foundation (A.S., K.D.) and MRC (T.C).
- Donaldson K: The inhalation toxicology of p-aramid fibrils. Crit Rev Toxicol 2009, 39:487–500.PubMedView Article
- Mossman BT, Lippmann M, Hesterberg TW, Kelsey KT, Barchowsky A, Bonner JC: Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev 2011, 14:76–121.PubMedView ArticlePubMed Central
- Oberdorster G: Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int Arch Occup Environ Health 2000,73(Suppl:S60–8):S60-S68.PubMedView Article
- Poland CA, Byrne F, Cho WS, Prina-Mello A, Murphy FA, Davies GL, et al.: Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity. Nanotoxicology 2011, 6:899–911.PubMedView Article
- Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Friend S, et al.: Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol 2011, 8:21.PubMedView ArticlePubMed Central
- Donaldson K, Murphy FA, Duffin R, Poland CA: Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010,7(5):5.PubMedView ArticlePubMed Central
- Davis JM, Beckett ST, Bolton RE, Collings P, Middleton AP: Mass and number of fibres in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer 1987, 37:673–688.View Article
- Davis JM, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T: The pathogenicity of long versus short fibre samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol 1986, 67:415–430.PubMedPubMed Central
- Schinwald A, Murphy FA, Prina-Mello A, Poland CA, Byrne F, Movia D, et al.: The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci 2012, 128:461–470.PubMedView Article
- Coin PG, Osornio-Vargas AR, Roggli VL, Brody AR: Pulmonary fibrogenesis after three consecutive inhalation exposures to chrysotile asbestos. Am J Respir Crit Care Med 1996, 154:1511–1519.PubMedView Article
- Searl A, Buchanan D, Cullen RT, Jones AD, Miller BG, Soutar CA: Biopersistence and durability of nine mineral fibre types in rat lungs over 12 months. Ann Occup Hyg 1999, 43:143–153.PubMedView Article
- Schinwald A, Donaldson K: Use of back-scatter electron signals to visualise cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long fibres in macrophages and compartmentalisation in mesothelial cells in vivo. Part Fibre Toxicol 2012, 9:34.PubMedView ArticlePubMed Central
- Stanton MF, Layard M, Tegeris A, Miller E, May M, Morgan E, et al.: Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. JNCI 1981, 67:965–975.PubMed
- Vorwald AJ, Durkan TM, Pratt PC: Experimental studies of asbestosis. AMA Arch Ind Hyg Occup Med 1951, 3:1–43.PubMed
- Murphy FA, Poland CA, Duffin R, Al-Jamal KT, Ali-Boucetta H, Nunes A, et al.: Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 2011, 178:2587–2600.PubMedView ArticlePubMed Central
- Murphy FA, Poland CA, Duffin R, Donaldson K: Length-dependent pleural inflammation and parietal pleural responses after deposition of carbon nanotubes in the pulmonary airspaces of mice. Nanotoxicology 2012, 6:2587–2600.
- Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, et al.: Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423–428.PubMedView Article
- Schinwald A, Murphy F, Prina-Mello A, Poland CA, Byrne F, Glass JR, et al.: The threshold length for fibre-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci in press
- Stebounova LV, mcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, et al.: Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 2011, 8:5.PubMedView ArticlePubMed Central
- Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, et al.: Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague–Dawley rats. Inhal Toxicol 2007, 19:857–871.PubMedView Article
- Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V: A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 2010, 40:328–346.PubMedView Article
- Oberdorster G: Lung dosimetry: pulmonary clearance of inhaled particles. Aerosol Sci Tech 1993, 18:279–289.View Article
- Lippmann M: Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect 1990, 88:311–317.PubMedView ArticlePubMed Central
- Lehnert BE: Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ Health Perspect 1992, 97:17–46.PubMedView ArticlePubMed Central
- Holt PF: Translocation of inhaled dust to the pleura. Environ Res 1983, 31:212–220.PubMedView Article
- Miserocchi G, Sancini G, Mantegazza F, Chiappino G: Translocation pathways for inhaled asbestos fibers. Environ Health 2008, 7:4.PubMedView ArticlePubMed Central
- Zhang Y, Wang B, Meng X, Sun G, Gao C: Influences of acid-treated multiwalled carbon nanotubes on fibroblasts: proliferation, adhesion, migration, and wound healing. Ann Biomed Eng 2011, 39:414–426.PubMedView Article
- Cannon GJ, Swanson JA: The macrophage capacity for phagocytosis. J Cell Sci 1992, 101:907–913.PubMed
- Krombach F, Munzing S, Allmeling AM, Gerlach JT, Behr J, Dorger M: Cell size of alveolar macrophages: an interspecies comparison. Environ Health Perspect 1997, 105:1261–1263.PubMedPubMed CentralView Article
- Abram CL, Lowell CA: The diverse functions of Src family kinases in macrophages. Front Biosci 2008, 13:4426–4450.PubMedView ArticlePubMed Central
- Lin T, Bost KL: STAT3 activation in macrophages following infection with Salmonella. Biochem Biophys Res Commun 2004, 321:828–834.PubMedView Article
- Looyenga BD, Hutchings D, Cherni I, Kingsley C, Weiss GJ, MacKeigan JP: STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma. PLoS One 2012., 7:
- Sablina AA, Chumakov PM, Kopnin BP: Tumor suppressor p53 and its homologue p73 alpha affect cell migration. J Biol Chem 2003, 278:27362–27371.PubMedView Article
- Berton S, Belletti B, Wolf K, Canzonieri V, Lovat F, Vecchione A, et al.: The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition. Mol Cell Biol 2009, 29:5031–5045.PubMedView ArticlePubMed Central
- Kobayashi T, Hino S, Oue N, Asahara T, Zollo M, Yasui W, et al.: Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions. Mol Cell Biol 2006, 26:898–911.PubMedView ArticlePubMed Central
- Ip CK, Wong AS: p70 S6 kinase and actin dynamics: a perspective. Spermatogenesis 2012, 2:44–52.PubMedView ArticlePubMed Central
- Roger L, Gadea G, Roux P: Control of cell migration: a tumour suppressor function for p53? Biol Cell 2006, 98:141–152.PubMedView Article
- Huang C, Rajfur Z, Borchers C, Schaller MD, Jacobson K: JNK phosphorylates paxillin and regulates cell migration. Nature 2003, 424:219–223.PubMedView Article
- Lee MH, Koria P, Qu J, Andreadis ST: JNK phosphorylates beta-catenin and regulates adherens junctions. FASEB J 2009, 23:3874–3883.PubMedView ArticlePubMed Central
- Yoon JH, Kim HE, Choi JY, Bae HJ, Lee SG: Caffeoylserotonin suppresses THP-1 monocyte adhesion and migration via inhibition of the integrin beta1/FAK/Akt signalling pathway. Fitoterapia 2012.
- Baruzzi A, Caveggion E, Berton G: Regulation of phagocyte migration and recruitment by Src-family kinases. Cell Mol Life Sci 2008, 65:2175–2190.PubMedView Article
- Donaldson K, Brown GM, Brown DM, Bolton RE, Davis JG: Inflammation generating potential of long and short fiber amosite asbestos samples. Br J Ind Med British 1989, 46:271–276.
- Rao GV, Tinkle S, Weissman DN, Antonini JM, Kashon ML, Salmen R, et al.: Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx. J Toxicol Environ Health A 2003, 66:1441–1452.PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.